Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroimmunol ; 84(2): 172-8, 1998 Apr 15.
Article in English | MEDLINE | ID: mdl-9628460

ABSTRACT

Myelin proteolipid protein (PLP) is a prime candidate autoantigen for multiple sclerosis. In order to define potential immunodominant epitopes, T cell lines (TCL) from the peripheral blood of HLA-DR 15(2) MS patients were established which responded to the intact molecule of PLP. These TCL were then tested in individual proliferation assays with a variety of PLP peptides spanning most of the PLP molecule. Multiple peptides were recognized by TCL from the MS population, with more than one peptide often recognized by lines from the same individual. Three immunodominant peptides were identified which were recognized by the majority of MS patients. Estimated frequency analyses were then performed on the peripheral blood of HLA-DR15(2)-positive MS and control subjects using TCL initiated by the three immunodominant peptides, 40-60, 95-117, and 185-206. TCL from HLA-DR15 MS subjects recognized peptide 95-117 significantly more often than TCL from control subjects.


Subject(s)
Multiple Sclerosis/immunology , Myelin Proteolipid Protein/immunology , Myelin Proteolipid Protein/pharmacology , Peptide Fragments/immunology , Peptide Fragments/pharmacology , T-Lymphocytes/immunology , Adult , Amino Acid Sequence , Cell Division/drug effects , Cell Division/immunology , Cells, Cultured , Epitopes/blood , Epitopes/immunology , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Multiple Sclerosis/blood , Myelin Proteolipid Protein/blood , Peptide Fragments/blood , T-Lymphocytes/cytology , T-Lymphocytes/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...